Gene replacement therapy may improve survival in patients with spinal muscular atrophy type 1 (SMA1), according to data from a multicenter study conducted in the USA.
Gene replacement therapy may improve survival in patients with spinal muscular atrophy type 1 (SMA1), according to data from a multicenter study conducted in the USA.